Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P14
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -38.94% |
| Q2 2025 | -33.89% |
| Q1 2025 | -32.05% |
| Q4 2024 | 57.83% |
| Q3 2024 | -17.37% |
| Q2 2024 | -35.36% |
| Q1 2024 | -34.69% |
| Q4 2023 | -12.05% |
| Q3 2023 | 147.89% |
| Q2 2023 | -21.88% |
| Q1 2023 | 172.68% |
| Q4 2022 | -6957.61% |
| Q3 2022 | -75.87% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |